PR

Pramod Reddy Yerra

Director Designated Partner DIN 06656137
DIN 06656137 First appointment Feb 2014 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Pramod Reddy Yerra

Data last updated:

Pramod Reddy Yerra was a Designated Partner at Align Hospitals Llp (2014–2017) and Director at Alice Therapeutics Private Limited (from 2014). The companies operate in Healthcare.

DIN 06656137
Primary Designation Designated Partner
Industry Healthcare
First Appointment 14 Feb 2014
Oldest Company Age 13 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner16 Sep 20142014Strike Off
Alice Therapeutics Private Limited U24248TG2013PTC090780
Director14 Feb 20142013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alice Therapeutics Private Limited
Align Hospitals Llp
Premium access

Shareholding and investment profile for Pramod Reddy Yerra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pramod Reddy Yerra

Pramod Reddy Yerra was first appointed on 14 Feb 2014 as Director at Alice Therapeutics Private Limited.

Pramod Reddy Yerra held 2 earlier board appointments: Align Hospitals Llp (Designated Partner, 16 Sep 2014 to 23 Feb 2017); Alice Therapeutics Private Limited (Director, from 14 Feb 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available